Day 1 : September 25, 2006 |
| 8:45 |
Session 1: DNA variation |
| |
| 8:45-9:05 |
Introduction & overview of disease genetics methods |
M. Lathrop |
| 9:05-9:35 |
Characterising DNA variation |
I. Gut |
| |
| 9:35 |
Session 2: Disease application examples I |
| |
| 9:35-10:05 |
Linkage studies to identify genes in diabetes |
C. Julier |
| 10:05-10:35 |
Candidate gene studies in infectious disease |
A. Sakuntabhai |
| |
|
|
| |
Coffee |
|
| |
|
|
| 11:05-11:35 |
Large-scale association studies to identify genetic modifiers of hemoglobinopathies |
S.-L. Thein |
| 11:35-12:05 |
GABRIEL : Genomic epidemiology of asthma |
B. Cookson |
| |
| |
|
|
| 12:05 |
Session 3: Comparative Genomics |
| |
|
|
| 12:05-12:35 |
Molecular dissection of QTLs in rodents and humans |
D. Gauguier |
| 12:35-13:05 |
Dissection of immune-related traits using ENU |
R. Cornall |
| |
|
|
| |
Lunch |
|
| |
|
|
| 14:15-14:45 |
Selective sweeps and positional identification of trait loci in chicken |
L. Andersson |
| 14:45-15:15 |
QTLs in cattle |
A. Eggen |
| 15:15-16:15 |
Perspectives on genomics in the mouse |
P. Avner |
| |
|
|
| |
Coffee |
|
| |
|
|
| 16:45-17:15 |
Polymorphic miRNA-target interactions: a novel source of phenotypic variation |
M. Georges |
| |
|
|
| |
|
|
| 17:15 |
Session 4: Study design and data interpretation I |
| |
|
|
| 17:15-17:45 |
Quantitative trait analysis |
M.Farrall |
| 17:45-18:15 |
Genome-wide association mapping in bacteria |
D. Falush |
| |
|
|
Day 2: September 26, 2006 |
| 8:45 |
Session 5: Copy number variation |
| |
| 8:45-9:05 |
Clinical applications |
A. Verloes |
| 9:05-9:25 |
Mental retardation |
L. Colleaux |
| 9:25-9:40 |
Comparison of methodologies |
M. Lathrop |
| 9:40-10:00 |
Initiatives for research on rare disorders & discussion |
E. Tournier-Lasserve |
| |
|
|
| 10:00 |
Session 6: Disease applications II |
| |
|
|
| 10:00-10:30 |
Genetics of neuropsychiatric disease |
T. Bourgeron |
| |
|
|
| |
Coffee |
|
| |
|
|
| 10:50-11:20 |
Genetics of autism |
J. Hager |
| 11:20-11:50 |
Epilepsy and language disorders |
P. Szepetowski |
| 11:50-12:20 |
The AMEN project for neurological disease |
P. Legrain |
| |
| 12:20 |
Session 7: Genetics, public health and society |
| |
| 12:20-12:55 |
Biobank UK |
R. Collins |
| |
| |
|
|
| |
|
|
| 14:00-14:30 |
A platform for GE3Ls studies |
A. Cambon-Thomsen |
| |
|
|
| 14:30 |
Session 8: Study design and data interpretation II |
| |
|
|
| 14:30-15:00 |
Using Hapmap data |
L. Cardon |
| |
|
|
| 15:00 |
Session 9: Other methodologies |
| |
|
|
| 15:00-15:30 |
Molecular tools for disease studies |
U. Landegren |
| 15:30-15:50 |
Biomarker profiling |
S. Schwonbeck |
| |
|
|
| |
Coffee |
|
| |
|
|
| 16:20-16:40 |
Protein arrays |
I. Gut |
| 16:40-17:10 |
Cell micro-arrays |
X. Gidrol |
| 17:10-17:40 |
Wallenberg initiative in proteomics |
M. Uhlen |
| |
|
|
| 18:00 |
End |
|
| |
|
|
